Department of Pharmacology

Vanderbilt researchers are studying how mutations in the receptor for light, rhodopsin, cause light blindness.

Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug.

New mass spectrometry imaging methods will enable studies of the distribution and identification of membrane proteins directly within tissues.

A biomarker for oxidative stress is elevated in patients with both autism spectrum disorder and gastrointestinal dysfunction, suggesting opportunities for individualized approaches to clinical care.

A genetic variant that increases risk for atrial fibrillation also impacts the response to a common therapy for the heart rhythm disorder.

The inner ear system that senses gravity and movement plays a role in bone remodeling – a finding that has clinical implications for space travel and for patients with inner ear disorders.

A “profile” of the genes and regulatory networks that govern early heart valve development lay the groundwork for generating valves from a patient’s own cells.